ABSTRACT Methicillin-resistant Staphylococcus aureus (MRSA) is a major pathogen causing nosocomial infections, and the clinical manifestations of MRSA range from asymptomatic colonization of the nasal mucosa to soft tissue infection to fulminant invasive disease. Here, we report the complete genome sequences of eight MRSA strains isolated from patients in Japan.
S
taphylococcus aureus is a causative agent that triggers a wide range of clinical infections, such as bacteremia, catheter-associated infections, and surgical site infections (1, 2) . Among S. aureus strains, methicillin-resistant Staphylococcus aureus (MRSA) is a representative drug-resistant bacterium and one of the most successful modern pathogens, accounting for 60% of clinical S. aureus infections in Japan (3) . Vancomycin and daptomycin are the agents of choice for acceptable treatment of invasive MRSA infections. Alternative agents that may be used for second-line or salvage therapy include telavancin, ceftaroline, and linezolid (4). However, it has recently been reported that acquisition of the vanA gene cluster during antibiotic therapy leads to resistance to vancomycin (5) . Here, we report the complete genome sequence of eight MRSA strains isolated in Japan, which showed multidrug resistance and possessed related genes in their plasmids. This genome information could help understanding of the multidrug resistance machinery of S. aureus.
Eight MRSA strains were isolated from the specimens of patients during the period of 2004 through 2018 and identified according to CLSI approved standard M100. All clinical samples were cultured on sheep blood agar, chocolate agar, and Drigalski agar at 35°C for 24 h, and the colonies were selected and then identified using matrixassisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). The Kyoto University institutional review board approved the protocol for use of the clinical data and strains.
Eight MRSA strains were incubated for 15 h at 37°C in Trypticase soy medium. The bacterial cells were lysed with lysostaphin and lysozyme, and then the genomic DNA was extracted by the phenol-chloroform extraction method. Extracted DNA was sequenced by a combination of short-read and long-read sequencing platforms. An Illumina short-read library was prepared using a Nextera DNA library prep kit, and paired-end reads were generated using a MiSeq reagent kit (v3-600) on the MiSeq platform (Illumina). A MinION long-read library was prepared from unsheared genomic DNA using the Rapid Barcoding kit (catalog number SQK-RBK004) and sequenced with an R9 flow cell (FLO-MIN106) on a MinION device (Oxford Nanopore Technologies). The Illumina data were preprocessed using Trimmomatic (v0.36) to remove adapter and low-quality sequences (6), and hybrid assembly with the MinION long reads was performed using the Unicycler pipeline (v0.4.7b) with default parameters (7) . Next, the assembled genome sequence was annotated using Prokka (v1.11) with default settings (8) . Assembly statistics, general genome information, and relevant characteristics are summarized in Table 1 . Among the eight MRSA genomes, seven strains (excluding strain KUH140087) have a 3-to 30-kb plasmid carrying similar antimicrobial or antiseptic resistance genes [aac(6=)-Ie, aph(2Љ)-Ia, qacA, qacB, aph(2Љ)-If, fosD, and blaZ] in different combinations. It has been reported that genes for drug resistance are often derived from plasmids (9, 10) , suggesting the importance of the investigation of antibiotic resistance plasmids for understanding S. aureus infection and its future treatments.
Data availability. The complete genome sequences of eight MRSA strains in this study have been deposited in DDBJ/EMBL/GenBank under accession numbers AP020311 to AP020325. The raw Illumina and MinION read data can be found in the DDBJ Sequence Read Archive/NCBI SRA under accession number DRA008776.
